[Form 4] Transcat Inc Insider Trading Activity

Rhea-AI Filing Summary

Credo Technology Group Holding Ltd. (NASDAQ: CRDO) has filed a Form 144 notifying the SEC of an intended sale of 1,875 common shares, valued at approximately $209,156. The shares, acquired via Restricted Stock Units, account for less than 0.001% of the company’s 171.6 million shares outstanding. The proposed trade is scheduled on or after 01 Aug 2025 through Morgan Stanley Smith Barney LLC and will be executed on the NASDAQ. No other securities have been sold by the filer in the past three months, and the signatory affirms possession of no undisclosed material adverse information under Rule 144 and Rule 10b5-1. The filing contains no additional financial metrics, earnings updates, or corporate events.

Insights

Securities Analyst

TL;DR: Planned insider sale of 1,875 CRDO shares (~$209k) is immaterial; neutral for valuation.

The notice covers a tiny fraction of CRDO’s float—roughly 0.001%—so it is unlikely to influence liquidity or price discovery. The shares stem from RSU vesting rather than discretionary open-market purchases, suggesting routine diversification. Absence of past-quarter sales further limits signaling value. With no accompanying operational data, the filing is best viewed as neutral housekeeping.

Corporate Governance Expert

TL;DR: Routine Form 144; complies with disclosure rules, no red flags.

The filer certified awareness of no undisclosed negative information, satisfying Rule 144 requirements. Use of a major broker and stated 10b5-1 safeguards reinforce procedural integrity. Given the de-minimis size, this transaction should not raise governance concerns or trigger aggregation thresholds.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HADEED CHARLES P

(Last) (First) (Middle)

C/O TRANSCAT, INC.

35 VANTAGE POINT DRIVE

(Street)

ROCHESTER NY 14624

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSCAT INC [ TRNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.50 par value	07/31/2025		M		704	A	$0(1)	22,480	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	07/31/2025		M			704	(1)	(1)	Common Stock, $.50 par value	704	$0	0	D

Explanation of Responses:

1. The issuer's Compensation Committee approved the accelerated vesting of Mr. Hadeed's outstanding restricted stock units to July 31, 2025 in connection with Mr. Hadeed's retirement as a director.

	/s/ Scott D. Deverell, Attorney-in-Fact for Charles P. Hadeed	08/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.